Digestive System Diseases Recruiting Phase 1 / 2 Trials for Irinotecan (DB00762)

Also known as: Digestive System Disease

IndicationStatusPhase
DBCOND0033030 (Digestive System Diseases)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03535727A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic CancerTreatment